Amarna Stem Cells BV is a company developing an autologous stem cell therapy to treat patients with a spinal cord injury or patients suffering a neurodegenerative disease. The company is integrated in the Brightlands community in the South of the Netherlands. The company owns a patented platform technology to process bone marrow and blood. The platform technology AMARYLLIS can be used to manufacture products to treat patients but can also be licensed to produce samples for research purposes only. Amarna Stem cells BV is very ambitious and the staff is highly experienced in developing cell based products and deal with all kind of regulatory issues and issues related to reimbursement research. The company is translational and science driven.